BioNTech, Pfizer sue CureVac over COVID vaccine patent claims

Share!

Business Insurance - Jul 26, 2022

COVID-19 vaccine maker BioNTech said Tuesday that it and partner Pfizer filed a complaint in U.S. District Court in Massachusetts, seeking a judgment that they did not infringe U.S. patents held by rival CureVac....

Read Full Article

Recommended Articles

USI combines specialty units

Posted: Oct 15, 2025

...